{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:43:06Z","timestamp":1790476986455,"version":"4.1.0"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:00:00Z","timestamp":1661299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:00:00Z","timestamp":1661299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000055","name":"National Institute on Deafness and Other Communication Disorders","doi-asserted-by":"publisher","award":["R01 DC009222"],"award-info":[{"award-number":["R01 DC009222"]}],"id":[{"id":"10.13039\/100000055","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["JARO"],"DOI":"10.1007\/s10162-022-00866-y","type":"journal-article","created":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T22:02:45Z","timestamp":1661378565000},"page":"569-578","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Current Advances in Adeno-Associated Virus-Mediated Gene Therapy to Prevent Acquired Hearing Loss"],"prefix":"10.1007","volume":"23","author":[{"given":"Fan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumar","family":"Sambamurti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4425-8586","authenticated-orcid":false,"given":"Suhua","family":"Sha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,24]]},"reference":[{"key":"866_CR1","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1152\/physrev.00053.2017","volume":"98","author":"J Wang","year":"2018","unstructured":"Wang J, Puel JL (2018) Toward cochlear therapies. Physiol Rev 98:2477\u20132522","journal-title":"Physiol Rev"},{"key":"866_CR2","doi-asserted-by":"crossref","unstructured":"Kros CJ, Steyger PS (2019) Aminoglycoside- and cisplatin-induced ototoxicity: mechanisms and otoprotective strategies. Cold Spring Harb Perspect Med 9","DOI":"10.1101\/cshperspect.a033548"},{"key":"866_CR3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/13543784.2017.1269171","volume":"26","author":"SH Sha","year":"2017","unstructured":"Sha SH, Schacht J (2017) Emerging therapeutic interventions against noise-induced hearing loss. Expert Opin Investig Drugs 26:85\u201396","journal-title":"Expert Opin Investig Drugs"},{"key":"866_CR4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.neuroscience.2018.07.053","volume":"407","author":"PZ Wu","year":"2019","unstructured":"Wu PZ, Liberman LD, Bennett K, de Gruttola V, O\u2019Malley JT, Liberman MC (2019) Primary neural degeneration in the human cochlea: evidence for hidden hearing loss in the aging ear. Neuroscience 407:8\u201320","journal-title":"Neuroscience"},{"key":"866_CR5","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.otc.2018.01.006","volume":"51","author":"CS Brown","year":"2018","unstructured":"Brown CS, Emmett SD, Robler SK, Tucci DL (2018) Global hearing loss prevention. Otolaryngol Clin North Am 51:575\u2013592","journal-title":"Otolaryngol Clin North Am"},{"key":"866_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-981-13-6123-4_2","volume":"1130","author":"J Guo","year":"2019","unstructured":"Guo J, Chai R, Li H, Sun S (2019) Protection of hair cells from ototoxic drug-induced hearing loss. Adv Exp Med Biol 1130:17\u201336","journal-title":"Adv Exp Med Biol"},{"key":"866_CR7","doi-asserted-by":"crossref","unstructured":"Nyberg S, Abbott NJ, Shi X, Steyger PS, Dabdoub A (2019) Delivery of therapeutics to the inner ear: the challenge of the blood-labyrinth barrier. Sci Transl Med 11","DOI":"10.1126\/scitranslmed.aao0935"},{"key":"866_CR8","doi-asserted-by":"publisher","first-page":"4496","DOI":"10.1073\/pnas.1817537116","volume":"116","author":"O Akil","year":"2019","unstructured":"Akil O, Dyka F, Calvet C, Emptoz A et al (2019) Dual AAV-mediated gene therapy restores hearing in a DFNB9 mouse model. Proc Natl Acad Sci U S A 116:4496\u20134501","journal-title":"Proc Natl Acad Sci U S A"},{"key":"866_CR9","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/s41591-019-0500-9","volume":"25","author":"B Gyorgy","year":"2019","unstructured":"Gyorgy B, Nist-Lund C, Pan B et al (2019) Allele-specific gene editing prevents deafness in a model of dominant progressive hearing loss. Nat Med 25:1123\u20131130","journal-title":"Nat Med"},{"key":"866_CR10","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.ymthe.2020.11.016","volume":"29","author":"J Wu","year":"2021","unstructured":"Wu J, Solanes P, Nist-Lund C, Spataro S, Shubina-Oleinik O, Marcovich I, Goldberg H, Schneider BL, Holt JR (2021) Single and dual vector gene therapy with AAV9-PHP.B rescues hearing in Tmc1 mutant mice. Mol Ther 29:973\u2013988","journal-title":"Mol Ther"},{"key":"866_CR11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ymthe.2021.06.015","volume":"30","author":"Y Xue","year":"2022","unstructured":"Xue Y, Hu X, Wang D et al (2022) Gene editing in a Myo6 semi-dominant mouse model rescues auditory function. Mol Ther 30:105\u2013118","journal-title":"Mol Ther"},{"key":"866_CR12","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1089\/hum.2015.025","volume":"26","author":"E Hastie","year":"2015","unstructured":"Hastie E, Samulski RJ (2015) Adeno-associated virus at 50: a golden anniversary of discovery, research, and gene therapy success\u2014a personal perspective. Hum Gene Ther 26:257\u2013265","journal-title":"Hum Gene Ther"},{"key":"866_CR13","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s40259-017-0234-5","volume":"31","author":"MF Naso","year":"2017","unstructured":"Naso MF, Tomkowicz B, Perry WL 3rd, Strohl WR (2017) Adeno-associated virus (AAV) as a vector for gene therapy. BioDrugs 31:317\u2013334","journal-title":"BioDrugs"},{"key":"866_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.heares.2020.107947","volume":"394","author":"C Askew","year":"2020","unstructured":"Askew C, Chien WW (2020) Adeno-associated virus gene replacement for recessive inner ear dysfunction: progress and challenges. Hear Res 394:107947","journal-title":"Hear Res"},{"key":"866_CR15","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.omtm.2021.03.005","volume":"21","author":"K Bankoti","year":"2021","unstructured":"Bankoti K, Generotti C, Hwa T, Wang L, O\u2019Malley BW Jr, Li D (2021) Advances and challenges in adeno-associated viral inner-ear gene therapy for sensorineural hearing loss. Mol Ther Methods Clin Dev 21:209\u2013236","journal-title":"Mol Ther Methods Clin Dev"},{"key":"866_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.652215","volume":"15","author":"R Crane","year":"2021","unstructured":"Crane R, Conley SM, Al-Ubaidi MR, Naash MI (2021) Gene therapy to the retina and the cochlea. Front Neurosci 15:652215","journal-title":"Front Neurosci"},{"key":"866_CR17","doi-asserted-by":"publisher","first-page":"7497","DOI":"10.1523\/JNEUROSCI.0782-16.2016","volume":"36","author":"K Hill","year":"2016","unstructured":"Hill K, Yuan H, Wang X, Sha SH (2016) Noise-induced loss of hair cells and cochlear synaptopathy are mediated by the activation of AMPK. J Neurosci 36:7497\u20137510","journal-title":"J Neurosci"},{"key":"866_CR18","first-page":"13","volume":"66","author":"Y Maeda","year":"2009","unstructured":"Maeda Y, Sheffield AM, Smith RJH (2009) Therapeutic regulation of gene expression in the inner ear using RNA interference. Adv Otorhinolaryngol 66:13\u201336","journal-title":"Adv Otorhinolaryngol"},{"key":"866_CR19","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1089\/ars.2010.3110","volume":"13","author":"D Mukherjea","year":"2010","unstructured":"Mukherjea D, Jajoo S, Kaur T, Sheehan KE, Ramkumar V, Rybak LP (2010) Transtympanic administration of short interfering (si)RNA for the NOX3 isoform of NADPH oxidase protects against cisplatin-induced hearing loss in the rat. Antioxid Redox Signal 13:589\u2013598","journal-title":"Antioxid Redox Signal"},{"key":"866_CR20","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.heares.2012.10.011","volume":"296","author":"N Oishi","year":"2013","unstructured":"Oishi N, Chen FQ, Zheng HW, Sha SH (2013) Intra-tympanic delivery of short interfering RNA into the adult mouse cochlea. Hear Res 296:36\u201341","journal-title":"Hear Res"},{"key":"866_CR21","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1007\/s11064-011-0474-6","volume":"36","author":"M Tanaka","year":"2011","unstructured":"Tanaka M, Asaoka M, Yanagawa Y, Hirashima N (2011) Long-term gene-silencing effects of siRNA introduced by single-cell electroporation into postmitotic CNS neurons. Neurochem Res 36:1482\u20131489","journal-title":"Neurochem Res"},{"key":"866_CR22","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1126\/science.149.3685.754","volume":"149","author":"RW Atchison","year":"1965","unstructured":"Atchison RW, Casto BC, Hammon WM (1965) Adenovirus-associated defective virus particles. Science 149:754\u2013756","journal-title":"Science"},{"key":"866_CR23","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1073\/pnas.55.6.1467","volume":"55","author":"MD Hoggan","year":"1966","unstructured":"Hoggan MD, Blacklow NR, Rowe WP (1966) Studies of small DNA viruses found in various adenovirus preparations: physical, biological, and immunological characteristics. Proc Natl Acad Sci U S A 55:1467\u20131474","journal-title":"Proc Natl Acad Sci U S A"},{"key":"866_CR24","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1146\/annurev-virology-031413-085355","volume":"1","author":"RJ Samulski","year":"2014","unstructured":"Samulski RJ, Muzyczka N (2014) AAV-mediated gene therapy for research and therapeutic purposes. Annu Rev Virol 1:427\u2013451","journal-title":"Annu Rev Virol"},{"key":"866_CR25","doi-asserted-by":"publisher","first-page":"10405","DOI":"10.1073\/pnas.162250899","volume":"99","author":"Q Xie","year":"2002","unstructured":"Xie Q, Bu W, Bhatia S, Hare J, Somasundaram T, Azzi A, Chapman MS (2002) The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy. Proc Natl Acad Sci U S A 99:10405\u201310410","journal-title":"Proc Natl Acad Sci U S A"},{"key":"866_CR26","doi-asserted-by":"publisher","first-page":"12686","DOI":"10.1128\/JVI.05359-11","volume":"85","author":"F Sonntag","year":"2011","unstructured":"Sonntag F, K\u00f6ther K, Schmidt K et al (2011) The assembly-activating protein promotes capsid assembly of different adeno-associated virus serotypes. J Virol 85:12686\u201312697","journal-title":"J Virol"},{"key":"866_CR27","doi-asserted-by":"crossref","unstructured":"Earley LF, Powers JM, Adachi K, Baumgart JT, Meyer NL, Xie Q, Chapman MS, Nakai H (2017) Adeno-associated virus (AAV) assembly-activating protein is not an essential requirement for capsid assembly of AAV serotypes 4, 5, and 11. J Virol 91","DOI":"10.1128\/JVI.01980-16"},{"key":"866_CR28","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nature02399","volume":"428","author":"J Grimwood","year":"2004","unstructured":"Grimwood J, Gordon LA, Olsen A et al (2004) The DNA sequence and biology of human chromosome 19. Nature 428:529\u2013535","journal-title":"Nature"},{"key":"866_CR29","doi-asserted-by":"publisher","first-page":"11511","DOI":"10.1128\/JVI.74.24.11511-11521.2000","volume":"74","author":"GE Tullis","year":"2000","unstructured":"Tullis GE, Shenk T (2000) Efficient replication of adeno-associated virus type 2 vectors: a cis-acting element outside of the terminal repeats and a minimal size. J Virol 74:11511\u201311521","journal-title":"J Virol"},{"key":"866_CR30","doi-asserted-by":"publisher","first-page":"6381","DOI":"10.1128\/JVI.78.12.6381-6388.2004","volume":"78","author":"G Gao","year":"2004","unstructured":"Gao G, Vandenberghe LH, Alvira MR, Lu Y, Calcedo R, Zhou X, Wilson JM (2004) Clades of adeno-associated viruses are widely disseminated in human tissues. J Virol 78:6381\u20136388","journal-title":"J Virol"},{"key":"866_CR31","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12985-021-01555-7","volume":"18","author":"R Colon-Thillet","year":"2021","unstructured":"Colon-Thillet R, Jerome KR, Stone D (2021) Optimization of AAV vectors to target persistent viral reservoirs. Virol J 18:85","journal-title":"Virol J"},{"key":"866_CR32","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/mt.2011.287","volume":"20","author":"A Asokan","year":"2012","unstructured":"Asokan A, Schaffer DV, Samulski RJ (2012) The AAV vector toolkit: poised at the clinical crossroads. Mol Ther 20:699\u2013708","journal-title":"Mol Ther"},{"key":"866_CR33","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.ymthe.2006.05.009","volume":"14","author":"Z Wu","year":"2006","unstructured":"Wu Z, Asokan A, Samulski RJ (2006) Adeno-associated virus serotypes: vector toolkit for human gene therapy. Mol Ther 14:316\u2013327","journal-title":"Mol Ther"},{"key":"866_CR34","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/978-1-61779-370-7_3","volume":"807","author":"M Agbandje-McKenna","year":"2011","unstructured":"Agbandje-McKenna M, Kleinschmidt J (2011) AAV capsid structure and cell interactions. Methods Mol Biol 807:47\u201392","journal-title":"Methods Mol Biol"},{"key":"866_CR35","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.omtm.2021.03.019","volume":"21","author":"MV Ivanchenko","year":"2021","unstructured":"Ivanchenko MV, Hanlon KS, Hathaway DM, Klein AJ, Peters CW, Li Y, Tamvakologos PI, Nammour J, Maguire CA, Corey DP (2021) AAV-S: a versatile capsid variant for transduction of mouse and primate inner ear. Mol Ther Methods Clin Dev 21:382\u2013398","journal-title":"Mol Ther Methods Clin Dev"},{"key":"866_CR36","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.cobme.2018.09.004","volume":"7","author":"EJ Lee","year":"2018","unstructured":"Lee EJ, Guenther CM, Suh J (2018) Adeno-associated virus (AAV) vectors: rational design strategies for capsid engineering. Curr Opin Biomed Eng 7:58\u201363","journal-title":"Curr Opin Biomed Eng"},{"key":"866_CR37","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.atherosclerosis.2018.09.005","volume":"278","author":"AE Vozenilek","year":"2018","unstructured":"Vozenilek AE, Blackburn CMR, Schilke RM, Chandran S, Castore R, Klein RL, Woolard MD (2018) AAV8-mediated overexpression of mPCSK9 in liver differs between male and female mice. Atherosclerosis 278:66\u201372","journal-title":"Atherosclerosis"},{"key":"866_CR38","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41591-019-0738-2","volume":"26","author":"A Moretti","year":"2020","unstructured":"Moretti A, Fonteyne L, Giesert F et al (2020) Somatic gene editing ameliorates skeletal and cardiac muscle failure in pig and human models of Duchenne muscular dystrophy. Nat Med 26:207\u2013214","journal-title":"Nat Med"},{"key":"866_CR39","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1681\/ASN.2018040426","volume":"29","author":"Y Ikeda","year":"2018","unstructured":"Ikeda Y, Sun Z, Ru X, Vandenberghe LH, Humphreys BD (2018) Efficient gene transfer to kidney mesenchymal cells using a synthetic adeno-associated viral vector. J Am Soc Nephrol 29:2287\u20132297","journal-title":"J Am Soc Nephrol"},{"key":"866_CR40","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1089\/hum.2017.154","volume":"29","author":"LS Carvalho","year":"2018","unstructured":"Carvalho LS, Xiao R, Wassmer SJ et al (2018) Synthetic adeno-associated viral vector efficiently targets mouse and nonhuman primate retina in vivo. Hum Gene Ther 29:771\u2013784","journal-title":"Hum Gene Ther"},{"key":"866_CR41","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/nbt.3781","volume":"35","author":"LD Landegger","year":"2017","unstructured":"Landegger LD, Pan B, Askew C et al (2017) A synthetic AAV vector enables safe and efficient gene transfer to the mammalian inner ear. Nat Biotechnol 35:280\u2013284","journal-title":"Nat Biotechnol"},{"key":"866_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2019.113167","volume":"326","author":"W Chiha","year":"2020","unstructured":"Chiha W, Bartlett CA, Petratos S, Fitzgerald M, Harvey AR (2020) Intravitreal application of AAV-BDNF or mutant AAV-CRMP2 protects retinal ganglion cells and stabilizes axons and myelin after partial optic nerve injury. Exp Neurol 326:113167","journal-title":"Exp Neurol"},{"key":"866_CR43","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.coviro.2016.08.001","volume":"21","author":"GE Berry","year":"2016","unstructured":"Berry GE, Asokan A (2016) Cellular transduction mechanisms of adeno-associated viral vectors. Curr Opin Virol 21:54\u201360","journal-title":"Curr Opin Virol"},{"key":"866_CR44","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.15252\/emmm.201404077","volume":"6","author":"T Cronin","year":"2014","unstructured":"Cronin T, Vandenberghe LH, Hantz P et al (2014) Efficient transduction and optogenetic stimulation of retinal bipolar cells by a synthetic adeno-associated virus capsid and promoter. EMBO Mol Med 6:1175\u20131190","journal-title":"EMBO Mol Med"},{"key":"866_CR45","doi-asserted-by":"crossref","unstructured":"Dalkara D, Byrne LC, Klimczak RR, Visel M, Yin L, Merigan WH, Flannery JG, Schaffer DV (2013) In vivo-directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous. Sci Transl Med 5:189ra176","DOI":"10.1126\/scitranslmed.3005708"},{"key":"866_CR46","doi-asserted-by":"crossref","unstructured":"Isgrig K, McDougald DS, Zhu J, Wang HJ, Bennett J, Chien WW (2019) AAV2.7m8 is a powerful viral vector for inner ear gene therapy. Nat Commun 10:427","DOI":"10.1038\/s41467-018-08243-1"},{"key":"866_CR47","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1089\/hum.2009.064","volume":"20","author":"JF Wright","year":"2009","unstructured":"Wright JF (2009) Transient transfection methods for clinical adeno-associated viral vector production. Hum Gene Ther 20:698\u2013706","journal-title":"Hum Gene Ther"},{"key":"866_CR48","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1093\/nar\/18.4.1068","volume":"18","author":"JP Morgenstern","year":"1990","unstructured":"Morgenstern JP, Land H (1990) A series of mammalian expression vectors and characterisation of their expression of a reporter gene in stably and transiently transfected cells. Nucleic Acids Res 18:1068","journal-title":"Nucleic Acids Res"},{"key":"866_CR49","doi-asserted-by":"publisher","first-page":"5665","DOI":"10.1046\/j.1432-1327.2000.01645.x","volume":"267","author":"K Van Craenenbroeck","year":"2000","unstructured":"Van Craenenbroeck K, Vanhoenacker P, Haegeman G (2000) Episomal vectors for gene expression in mammalian cells. Eur J Biochem 267:5665\u20135678","journal-title":"Eur J Biochem"},{"key":"866_CR50","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1089\/hum.2010.245","volume":"22","author":"SJ Gray","year":"2011","unstructured":"Gray SJ, Foti SB, Schwartz JW et al (2011) Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors. Hum Gene Ther 22:1143\u20131153","journal-title":"Hum Gene Ther"},{"key":"866_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010611","volume":"5","author":"JY Qin","year":"2010","unstructured":"Qin JY, Zhang L, Clift KL, Hulur I, Xiang AP, Ren BZ, Lahn BT (2010) Systematic comparison of constitutive promoters and the doxycycline-inducible promoter. PLoS ONE 5:e10611","journal-title":"PLoS ONE"},{"key":"866_CR52","first-page":"49","volume":"19","author":"SK Powell","year":"2015","unstructured":"Powell SK, Rivera-Soto R, Gray SJ (2015) Viral expression cassette elements to enhance transgene target specificity and expression in gene therapy. Discov Med 19:49\u201357","journal-title":"Discov Med"},{"key":"866_CR53","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1089\/hum.2010.055","volume":"21","author":"M Lock","year":"2010","unstructured":"Lock M, Alvira M, Vandenberghe LH, Samanta A, Toelen J, Debyser Z, Wilson JM (2010) Rapid, simple, and versatile manufacturing of recombinant adeno-associated viral vectors at scale. Hum Gene Ther 21:1259\u20131271","journal-title":"Hum Gene Ther"},{"key":"866_CR54","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1089\/hum.2010.250","volume":"22","author":"S Cecchini","year":"2011","unstructured":"Cecchini S, Virag T, Kotin RM (2011) Reproducible high yields of recombinant adeno-associated virus produced using invertebrate cells in 0.02- to 200-liter cultures. Hum Gene Ther 22:1021\u20131030","journal-title":"Hum Gene Ther"},{"key":"866_CR55","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1089\/hum.2009.070","volume":"20","author":"BA Thorne","year":"2009","unstructured":"Thorne BA, Takeya RK, Peluso RW (2009) Manufacturing recombinant adeno-associated viral vectors from producer cell clones. Hum Gene Ther 20:707\u2013714","journal-title":"Hum Gene Ther"},{"key":"866_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/mt.2013.268","volume":"22","author":"JF Wright","year":"2014","unstructured":"Wright JF (2014) AAV empty capsids: for better or for worse? Mol Ther 22:1\u20132","journal-title":"Mol Ther"},{"key":"866_CR57","doi-asserted-by":"publisher","first-page":"14034","DOI":"10.1038\/mtm.2014.34","volume":"1","author":"M Potter","year":"2014","unstructured":"Potter M, Lins B, Mietzsch M, Heilbronn R, Van Vliet K, Chipman P, Agbandje-McKenna M, Cleaver BD, Clement N, Byrne BJ, Zolotukhin S (2014) A simplified purification protocol for recombinant adeno-associated virus vectors. Mol Ther Methods Clin Dev 1:14034","journal-title":"Mol Ther Methods Clin Dev"},{"key":"866_CR58","doi-asserted-by":"publisher","first-page":"10346","DOI":"10.1128\/JVI.00841-06","volume":"80","author":"VW Choi","year":"2006","unstructured":"Choi VW, McCarty DM, Samulski RJ (2006) Host cell DNA repair pathways in adeno-associated viral genome processing. J Virol 80:10346\u201310356","journal-title":"J Virol"},{"key":"866_CR59","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1016\/j.ymthe.2021.08.031","volume":"29","author":"DA Dalwadi","year":"2021","unstructured":"Dalwadi DA, Calabria A, Tiyaboonchai A, Posey J, Naugler WE, Montini E, Grompe M (2021) AAV integration in human hepatocytes. Mol Ther 29:2898\u20132909","journal-title":"Mol Ther"},{"key":"866_CR60","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/ng0598-13","volume":"19","author":"CH Miao","year":"1998","unstructured":"Miao CH, Snyder RO, Schowalter DB, Patijn GA, Donahue B, Winther B, Kay MA (1998) The kinetics of rAAV integration in the liver. Nat Genet 19:13\u201315","journal-title":"Nat Genet"},{"key":"866_CR61","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.1128\/JVI.79.6.3606-3614.2005","volume":"79","author":"H Nakai","year":"2005","unstructured":"Nakai H, Wu X, Fuess S, Storm TA, Munroe D, Montini E, Burgess SM, Grompe M, Kay MA (2005) Large-scale molecular characterization of adeno-associated virus vector integration in mouse liver. J Virol 79:3606\u20133614","journal-title":"J Virol"},{"key":"866_CR62","doi-asserted-by":"publisher","first-page":"e1000985","DOI":"10.1371\/journal.ppat.1000985","volume":"6","author":"D H\u00fcser","year":"2010","unstructured":"H\u00fcser D, Gogol-D\u00f6ring A, Lutter T, Weger S, Winter K, Hammer E-M, Cathomen T, Reinert K, Heilbronn R (2010) Integration preferences of wildtype AAV-2 for consensus rep-binding sites at numerous loci in the human genome. PLoS Pathog 6:e1000985\u2013e1000985","journal-title":"PLoS Pathog"},{"key":"866_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/hgtb.2015.140","volume":"27","author":"K Chamberlain","year":"2016","unstructured":"Chamberlain K, Riyad JM, Weber T (2016) Expressing transgenes that exceed the packaging capacity of adeno-associated virus capsids. Hum Gene Ther Methods 27:1\u201312","journal-title":"Hum Gene Ther Methods"},{"key":"866_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.heares.2020.107912","volume":"394","author":"O Akil","year":"2020","unstructured":"Akil O (2020) Dual and triple AAV delivery of large therapeutic gene sequences into the inner ear. Hear Res 394:107912","journal-title":"Hear Res"},{"key":"866_CR65","doi-asserted-by":"crossref","unstructured":"Muhuri M, Maeda Y, Ma H, Ram S, Fitzgerald KA, Tai PW, Gao G (2021) Overcoming innate immune barriers that impede AAV gene therapy vectors. J Clin Invest 131","DOI":"10.1172\/JCI143780"},{"key":"866_CR66","doi-asserted-by":"crossref","unstructured":"Ronzitti G, Gross D-A, Mingozzi F (2020) Human immune responses to adeno-associated virus (AAV) vectors. Front Immunol 11","DOI":"10.3389\/fimmu.2020.00670"},{"key":"866_CR67","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/sj.gt.3302039","volume":"10","author":"JY Sun","year":"2003","unstructured":"Sun JY, Anand-Jawa V, Chatterjee S, Wong KK (2003) Immune responses to adeno-associated virus and its recombinant vectors. Gene Ther 10:964\u2013976","journal-title":"Gene Ther"},{"key":"866_CR68","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.omtm.2019.12.008","volume":"17","author":"AT Martino","year":"2020","unstructured":"Martino AT, Markusic DM (2020) Immune response mechanisms against AAV vectors in animal models. Mol Ther Methods Clin Dev 17:198\u2013208","journal-title":"Mol Ther Methods Clin Dev"},{"key":"866_CR69","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1182\/blood-2013-01-306647","volume":"122","author":"F Mingozzi","year":"2013","unstructured":"Mingozzi F, High KA (2013) Immune responses to AAV vectors: overcoming barriers to successful gene therapy. Blood 122:23\u201336","journal-title":"Blood"},{"key":"866_CR70","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1089\/hum.2011.031","volume":"22","author":"L Wang","year":"2011","unstructured":"Wang L, Calcedo R, Bell P, Lin J, Grant RL, Siegel DL, Wilson JM (2011) Impact of pre-existing immunity on gene transfer to nonhuman primate liver with adeno-associated virus 8 vectors. Hum Gene Ther 22:1389\u20131401","journal-title":"Hum Gene Ther"},{"key":"866_CR71","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1128\/JVI.01990-07","volume":"82","author":"AK Zaiss","year":"2008","unstructured":"Zaiss AK, Cotter MJ, White LR, Clark SA, Wong NC, Holers VM, Bartlett JS, Muruve DA (2008) Complement is an essential component of the immune response to adeno-associated virus vectors. J Virol 82:2727\u20132740","journal-title":"J Virol"},{"key":"866_CR72","doi-asserted-by":"crossref","unstructured":"Rabinowitz J, Chan YK, Samulski RJ (2019) Adeno-associated virus (AAV) versus immune response. Viruses 11","DOI":"10.3390\/v11020102"},{"key":"866_CR73","doi-asserted-by":"publisher","first-page":"45524","DOI":"10.1038\/srep45524","volume":"7","author":"J Suzuki","year":"2017","unstructured":"Suzuki J, Hashimoto K, Xiao R, Vandenberghe LH, Liberman MC (2017) Cochlear gene therapy with ancestral AAV in adult mice: complete transduction of inner hair cells without cochlear dysfunction. Sci Rep 7:45524","journal-title":"Sci Rep"},{"key":"866_CR74","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.1038\/s41467-019-11687-8","volume":"10","author":"F Tan","year":"2019","unstructured":"Tan F, Chu C, Qi J et al (2019) AAV-ie enables safe and efficient gene transfer to inner ear cells. Nat Commun 10:3733","journal-title":"Nat Commun"},{"key":"866_CR75","doi-asserted-by":"publisher","first-page":"15362","DOI":"10.1038\/s41598-019-51724-6","volume":"9","author":"K Hashimoto","year":"2019","unstructured":"Hashimoto K, Hickman TT, Suzuki J, Ji L, Kohrman DC, Corfas G, Liberman MC (2019) Protection from noise-induced cochlear synaptopathy by virally mediated overexpression of NT3. Sci Rep 9:15362","journal-title":"Sci Rep"},{"key":"866_CR76","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1006\/nimg.2000.0617","volume":"12","author":"M Ulfendahl","year":"2000","unstructured":"Ulfendahl M, Scarfone E, Flock A, Le Calvez S, Conradi P (2000) Perilymphatic fluid compartments and intercellular spaces of the inner ear and the organ of Corti. Neuroimage 12:307\u2013313","journal-title":"Neuroimage"},{"key":"866_CR77","doi-asserted-by":"publisher","first-page":"4825","DOI":"10.1038\/s41598-017-05151-0","volume":"7","author":"C Richard","year":"2017","unstructured":"Richard C, Courbon G, Laroche N, Prades JM, Vico L, Malaval L (2017) Inner ear ossification and mineralization kinetics in human embryonic development \u2014 microtomographic and histomorphological study. Sci Rep 7:4825","journal-title":"Sci Rep"},{"key":"866_CR78","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1038\/s41598-018-21233-z","volume":"8","author":"H Yoshimura","year":"2018","unstructured":"Yoshimura H, Shibata SB, Ranum PT, Smith RJH (2018) Enhanced viral-mediated cochlear gene delivery in adult mice by combining canal fenestration with round window membrane inoculation. Sci Rep 8:2980","journal-title":"Sci Rep"},{"key":"866_CR79","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/gt.2015.22","volume":"22","author":"H Jie","year":"2015","unstructured":"Jie H, Tao S, Liu L, Xia L, Charko A, Yu Z, Bance M, Yin S, Robertson GS, Wang J (2015) Cochlear protection against cisplatin by viral transfection of X-linked inhibitor of apoptosis protein across round window membrane. Gene Ther 22:546\u2013552","journal-title":"Gene Ther"},{"key":"866_CR80","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1002\/lary.25317","volume":"125","author":"WW Chien","year":"2015","unstructured":"Chien WW, McDougald DS, Roy S, Fitzgerald TS, Cunningham LL (2015) Cochlear gene transfer mediated by adeno-associated virus: comparison of two surgical approaches. Laryngoscope 125:2557\u20132564","journal-title":"Laryngoscope"},{"key":"866_CR81","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1089\/hum.2016.053","volume":"27","author":"Y Shu","year":"2016","unstructured":"Shu Y, Tao Y, Wang Z, Tang Y, Li H, Dai P, Gao G, Chen ZY (2016) Identification of adeno-associated viral vectors that target neonatal and adult mammalian inner ear cell subtypes. Hum Gene Ther 27:687\u2013699","journal-title":"Hum Gene Ther"},{"key":"866_CR82","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.omtm.2020.05.007","volume":"17","author":"R Omichi","year":"2020","unstructured":"Omichi R, Yoshimura H, Shibata SB, Vandenberghe LH, Smith RJH (2020) Hair cell transduction efficiency of single- and dual-AAV serotypes in adult murine cochleae. Mol Ther Methods Clin Dev 17:1167\u20131177","journal-title":"Mol Ther Methods Clin Dev"},{"key":"866_CR83","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/j.addr.2008.08.001","volume":"60","author":"EE Swan","year":"2008","unstructured":"Swan EE, Mescher MJ, Sewell WF, Tao SL, Borenstein JT (2008) Inner ear drug delivery for auditory applications. Adv Drug Deliv Rev 60:1583\u20131599","journal-title":"Adv Drug Deliv Rev"},{"key":"866_CR84","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1089\/hum.2017.120","volume":"29","author":"Y Tao","year":"2018","unstructured":"Tao Y, Huang M, Shu Y et al (2018) Delivery of adeno-associated virus vectors in adult mammalian inner-ear cell subtypes without auditory dysfunction. Hum Gene Ther 29:492\u2013506","journal-title":"Hum Gene Ther"},{"key":"866_CR85","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0378-5955(98)00214-7","volume":"129","author":"M Suzuki","year":"1999","unstructured":"Suzuki M, Kaga K (1999) Development of blood-labyrinth barrier in the semicircular canal ampulla of the rat. Hear Res 129:27\u201334","journal-title":"Hear Res"},{"key":"866_CR86","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0378-5955(97)00208-6","volume":"116","author":"M Suzuki","year":"1998","unstructured":"Suzuki M, Yamasoba T, Kaga K (1998) Development of the blood-labyrinth barrier in the rat. Hear Res 116:107\u2013112","journal-title":"Hear Res"},{"key":"866_CR87","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.ajhg.2016.03.028","volume":"98","author":"SB Shibata","year":"2016","unstructured":"Shibata SB, Ranum PT, Moteki H, Pan B, Goodwin AT, Goodman SS, Abbas PJ, Holt JR, Smith RJH (2016) RNA interference prevents autosomal-dominant hearing loss. Am J Hum Genet 98:1101\u20131113","journal-title":"Am J Hum Genet"},{"key":"866_CR88","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/jgm.2701","volume":"15","author":"Y Wang","year":"2013","unstructured":"Wang Y, Sun Y, Chang Q, Ahmad S, Zhou B, Kim Y, Li H, Lin X (2013) Early postnatal virus inoculation into the scala media achieved extensive expression of exogenous green fluorescent protein in the inner ear and preserved auditory brainstem response thresholds. J Gene Med 15:123\u2013133","journal-title":"J Gene Med"},{"key":"866_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.omtm.2018.11.003","volume":"13","author":"B Gyorgy","year":"2019","unstructured":"Gyorgy B, Meijer EJ, Ivanchenko MV et al (2019) Gene transfer with AAV9-PHP.B rescues hearing in a mouse model of usher syndrome 3A and transduces hair cells in a non-human primate. Mol Ther Methods Clin Dev 13:1\u201313","journal-title":"Mol Ther Methods Clin Dev"},{"key":"866_CR90","doi-asserted-by":"crossref","unstructured":"Ivanchenko MV, Hanlon KS, Devine MK, Tenneson K, Emond F, Lafond JF, Kenna MA, Corey DP, Maguire CA (2020) Preclinical testing of AAV9-PHP.B for transgene expression in the non-human primate cochlea. Hear Res 394:107930","DOI":"10.1016\/j.heares.2020.107930"},{"key":"866_CR91","doi-asserted-by":"crossref","unstructured":"Lee J, Nist-Lund C, Solanes P, Goldberg H, Wu J, Pan B, Schneider BL, Holt JR (2020) Efficient viral transduction in mouse inner ear hair cells with utricle injection and AAV9-PHP.B. Hear Res 394:107882","DOI":"10.1016\/j.heares.2020.107882"},{"key":"866_CR92","doi-asserted-by":"publisher","first-page":"3668","DOI":"10.1121\/1.5132550","volume":"146","author":"KK Ohlemiller","year":"2019","unstructured":"Ohlemiller KK (2019) Mouse methods and models for studies in hearing. J Acoust Soc Am 146:3668","journal-title":"J Acoust Soc Am"},{"key":"866_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000357770","volume":"4","author":"MK Ho","year":"2014","unstructured":"Ho MK, Li X, Wang J, Ohmen JD, Friedman RA (2014) FVB\/NJ mice demonstrate a youthful sensitivity to noise-induced hearing loss and provide a useful genetic model for the study of neural hearing loss. Audiol Neurotol Extra 4:1\u201311","journal-title":"Audiol Neurotol Extra"},{"key":"866_CR94","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00018-022-04268-4","volume":"79","author":"F Wu","year":"2022","unstructured":"Wu F, Hill K, Fang Q, He Z, Zheng H, Wang X, Xiong H, Sha SH (2022) Traumatic-noise-induced hair cell death and hearing loss is mediated by activation of CaMKKbeta. Cell Mol Life Sci 79:249","journal-title":"Cell Mol Life Sci"},{"key":"866_CR95","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1021\/acssynbio.9b00203","volume":"8","author":"X Wang","year":"2019","unstructured":"Wang X, Yuan C, Huang B et al (2019) Developing a versatile shotgun cloning strategy for single-vector-based multiplex expression of short interfering RNAs (siRNAs) in mammalian cells. ACS Synthe Bio 8:2092\u20132105","journal-title":"ACS Synthe Bio"},{"key":"866_CR96","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1128\/MMBR.67.4.657-685.2003","volume":"67","author":"N Agrawal","year":"2003","unstructured":"Agrawal N, Dasaradhi PV, Mohmmed A, Malhotra P, Bhatnagar RK, Mukherjee SK (2003) RNA interference: biology, mechanism, and applications. Microbiol Mol Biol 67:657\u2013685","journal-title":"Microbiol Mol Biol"},{"key":"866_CR97","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nrd.2018.20","volume":"17","author":"C Morrison","year":"2018","unstructured":"Morrison C (2018) Alnylam prepares to land first RNAi drug approval. Nat Rev Drug Discovery 17:156\u2013157","journal-title":"Nat Rev Drug Discovery"},{"key":"866_CR98","doi-asserted-by":"crossref","unstructured":"Bellosta S, Rossi C, Alieva AS, Catapano AL, Corsini A, Baragetti A (2022) Cholesterol lowering biotechnological strategies: from monoclonal antibodies to antisense therapies. a pre-clinical perspective review. Cardiovasc Drugs Ther","DOI":"10.1007\/s10557-021-07293-w"},{"key":"866_CR99","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41434-018-0012-0","volume":"25","author":"H Chen","year":"2018","unstructured":"Chen H, Xing Y, Xia L, Chen Z, Yin S, Wang J (2018) AAV-mediated NT-3 overexpression protects cochleae against noise-induced synaptopathy. Gene Ther 25:251\u2013259","journal-title":"Gene Ther"},{"key":"866_CR100","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/sj.mt.6300379","volume":"16","author":"Y Liu","year":"2008","unstructured":"Liu Y, Okada T, Shimazaki K et al (2008) Protection against aminoglycoside-induced ototoxicity by regulated AAV vector-mediated GDNF gene transfer into the cochlea. Mol Ther 16:474\u2013480","journal-title":"Mol Ther"},{"key":"866_CR101","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.3109\/00016489.2013.799777","volume":"133","author":"G Zheng","year":"2013","unstructured":"Zheng G, Zhu Z, Zhu K, Wei J, Jing Y, Duan M (2013) Therapeutic effect of adeno-associated virus (AAV)-mediated ADNF-9 expression on cochlea of kanamycin-deafened guinea pigs. Acta Otolaryngol 133:1022\u20131029","journal-title":"Acta Otolaryngol"},{"key":"866_CR102","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1089\/hum.2018.028","volume":"30","author":"O Akil","year":"2019","unstructured":"Akil O, Blits B, Lustig LR, Leake PA (2019) Virally mediated overexpression of glial-derived neurotrophic factor elicits age- and dose-dependent neuronal toxicity and hearing loss. Hum Gene Ther 30:88\u2013105","journal-title":"Hum Gene Ther"},{"key":"866_CR103","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1097\/00129492-200606000-00009","volume":"27","author":"LB Cooper","year":"2006","unstructured":"Cooper LB, Chan DK, Roediger FC, Shaffer BR, Fraser JF, Musatov S, Selesnick SH, Kaplitt MG (2006) AAV-mediated delivery of the caspase inhibitor XIAP protects against cisplatin ototoxicity. Otol Neurotol 27:484\u2013490","journal-title":"Otol Neurotol"},{"key":"866_CR104","doi-asserted-by":"publisher","first-page":"6490","DOI":"10.18632\/aging.102203","volume":"11","author":"F Qi","year":"2019","unstructured":"Qi F, Zhang R, Chen J et al (2019) Down-regulation of Cav1.3 in auditory pathway promotes age-related hearing loss by enhancing calcium-mediated oxidative stress in male mice. Aging 11:6490\u20136502","journal-title":"Aging"},{"key":"866_CR105","doi-asserted-by":"crossref","unstructured":"Mukherjee S, Kuroiwa M, Oakden W et al (2021) Local magnetic delivery of adeno-associated virus AAV2(quad Y-F)-mediated BDNF gene therapy restores hearing after noise injury. Mol Ther","DOI":"10.1016\/j.ymthe.2021.07.013"},{"key":"866_CR106","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13059-021-02311-4","volume":"22","author":"X Gu","year":"2021","unstructured":"Gu X, Wang D, Xu Z, Wang J, Guo L, Chai R, Li G, Shu Y, Li H (2021) Prevention of acquired sensorineural hearing loss in mice by in vivo Htra2 gene editing. Genome Biol 22:86","journal-title":"Genome Biol"},{"key":"866_CR107","doi-asserted-by":"publisher","DOI":"10.1002\/biot.202000025","volume":"16","author":"J El Andari","year":"2021","unstructured":"El Andari J, Grimm D (2021) Production, processing, and characterization of synthetic AAV gene therapy vectors. Biotechnol J 16:e2000025","journal-title":"Biotechnol J"},{"key":"866_CR108","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.omtm.2018.01.002","volume":"8","author":"M Penaud-Budloo","year":"2018","unstructured":"Penaud-Budloo M, Francois A, Clement N, Ayuso E (2018) Pharmacology of recombinant adeno-associated virus production.\u00a0Mol Ther Methods Clin Dev\u00a08:166\u2013180","journal-title":"Molecular therapy Methods & clinical development"}],"container-title":["Journal of the Association for Research in Otolaryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10162-022-00866-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10162-022-00866-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10162-022-00866-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T07:09:20Z","timestamp":1667113760000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10162-022-00866-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,24]]},"references-count":108,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["866"],"URL":"https:\/\/doi.org\/10.1007\/s10162-022-00866-y","relation":{},"ISSN":["1438-7573"],"issn-type":[{"value":"1438-7573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,24]]},"assertion":[{"value":"6 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}